Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Genomic Statistics and Bioinformatics, |
RCV001175330 | SCV001288156 | likely pathogenic | Congenital myasthenic syndrome 4A | criteria provided, single submitter | clinical testing | Using trio-exome sequencing and analysis of the genes with the ten highest PEDIA values (PMID: 31164752), as well as of genes which could be associated with a delay in development (n=2539), a missense variant in exon 12 of the CHRNE gene could be found in the patient which could possibly be the cause of his symptoms. The name of the variant is NM_000080.3:c.1457C> T;p.(Pro486Leu) . This variant could not be detected in the parents and therefore, it is very likely that it was newly (de novo) developed in the patient. The variant is currently not listed in any phanotype-related or population-related databases. The mutation prediction programs MutationTaster, SIFT and Polyphen estimate the variant as pathogenic. The CADD score is 25.6. in silico analysis using the Alamut software does not provide any clear indication of a change in splicing behaviour with various prediction programs. The ACMG classification of the variant is: probably pathogenic (class 4: PS2, PM2, PP3). |